Diseases, Infectious

Transcript

Open Labs, Open Minds: Breaking Down the Barriers to Innovation and Access to Medicines in the Developing World

Speaker: Andrew Witty
Presider: Vijay V. Vaitheeswaran

Andrew Witty, Chief Executive Officer of Glaxosmithkline, speaks about innovative and economically sustainable new ways to ensure pharmaceutical access to populations in the developing world. This meeting is part of the CEO speaker series which aims to educate the CFR membership on the private sector's important role in the policy debate by engaging the global business community's top leadership. Members benefit from hearing CEOs' perspectives as well as interacting with them in an informal setting; in turn, CEOs have the opportunity to highlight the work of their organization and strengthen their relationship with CFR.

See more in Global; Diseases, Infectious; Pharmaceuticals and Vaccines

Audio

Open Labs, Open Minds: Breaking Down the Barriers to Innovation and Access to Medicines in the Developing World (Audio)

Speaker: Andrew Witty
Presider: Vijay V. Vaitheeswaran

Listen to GlaxoSmithKline CEO Andrew Witty discuss steps GSK is taking to address neglected tropical diseases and to ensure access to vaccines in the developing world.

This session was part of the Corporate Program's CEO Speaker series.

See more in Global; Diseases, Infectious; Pharmaceuticals and Vaccines

Other Report

The Evolution and Future of Donor Assistance for HIV/AIDS

Authors: Kammerle Schneider and Laurie Garrett

This Working Paper, a contribution to the aids2031 project, focuses on the future of donor financing for HIV prevention and treatment programs and makes recommendations for what the donor community and national governments can do now to build a foundation that ensures steady, long-term funding for HIV/AIDS and alleviates the impact of future challenges.

See more in Foreign Aid; Global; Diseases, Infectious